Quality of life and outcomes in patients⩾60 years of age after allogeneic hematopoietic cell transplantation

From Biology to Clinical Practice: Aging and Hematopoietic Cell Transplantation

(2012) Andrew S. Artz   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Allogeneic stem cell transplantation for elderly patients with myelodysplastic syndrome

(2012) N. Kroger   BLOOD

Randomized study of 2 reduced-intensity conditioning strategies for human leukocyte antigen-matched, related allogeneic peripheral blood stem cell transplantation

(2012) Didier Blaise et al.   CANCER

Myeloablative Reduced-Toxicity i.v. Busulfan-Fludarabine and Allogeneic Hematopoietic Stem Cell Transplant for Patients with Acute Myeloid Leukemia or Myelodysplastic Syndrome in the Sixth through Eighth Decades of Life

(2011) Gheath Alatrash et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Reduced-Intensity Conditioning before Allogeneic Hematopoietic Stem Cell Transplantation in Patients Over 60 Years: A Report from the SFGM-TC

(2011) Patrice Chevallier et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

A Prospective Study Comparing the Outcomes and Health-Related Quality of Life in Adult Patients with Myeloid Malignancies Undergoing Allogeneic Transplantation Using Myeloablative or Reduced-Intensity Conditioning

(2011) Vikas Gupta et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Similar outcomes using myeloablative vs reduced-intensity allogeneic transplant preparative regimens for AML or MDS

(2011) S M Luger et al.   BONE MARROW TRANSPLANTATION

Reduced-Intensity Conditioning Hematopoietic Stem Cell Transplantation in Patients Over 60 Years: Hematologic Malignancy Outcomes Are Not Impaired in Advanced Age

(2010) John Koreth et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Long-term recovery after hematopoietic cell transplantation: predictors of quality-of-life concerns

(2010) F. L. Wong et al.   BLOOD

Effect of Age on Outcome of Reduced-Intensity Hematopoietic Cell Transplantation for Older Patients With Acute Myeloid Leukemia in First Complete Remission or With Myelodysplastic Syndrome

(2010) Brian L. McClune et al.   JOURNAL OF CLINICAL ONCOLOGY

Measuring the Symptom Burden of Allogeneic Hematopoietic Stem Cell Transplantation in Patients With and Without Acute Graft-Versus-Host Disease

(2009) L.A. Williams et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Reduced-Intensity Conditioning Regimen Workshop: Defining the Dose Spectrum. Report of a Workshop Convened by the Center for International Blood and Marrow Transplant Research

(2009) Sergio Giralt et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Quality of life after allogeneic hematopoietic cell transplantation

(2009) J. Pidala et al.   BLOOD

A retrospective comparison of conventional intensity conditioning and reduced-intensity conditioning for allogeneic hematopoietic cell transplantation in myelofibrosis

(2009) V Gupta et al.   BONE MARROW TRANSPLANTATION

Reduced-intensity conditioning transplantation in myeloid malignancies

(2009) Rainer Storb   CURRENT OPINION IN ONCOLOGY

Reduced Intensity Conditioning Compared With Myeloablative Conditioning Using Unrelated Donor Transplants in Patients With Acute Myeloid Leukemia

(2009) Olle Ringdén et al.   JOURNAL OF CLINICAL ONCOLOGY

Allogeneic Hematopoietic Stem-Cell Transplantation for Patients 50 Years or Older With Myelodysplastic Syndromes or Secondary Acute Myeloid Leukemia

(2009) ZiYi Lim et al.   JOURNAL OF CLINICAL ONCOLOGY

Reduced intensity conditioning allogeneic stem cell transplantation for patients with acute myeloid leukemia: long term results of a ‘donor’ versus ‘no donor’ comparison

(2008) M Mohty et al.   LEUKEMIA